Propanc Biopharma, Inc. Common Stock Cash Flow Reinvestment Rate
Latest as of December 2024:
0.00x
Propanc Biopharma, Inc. Common Stock cash flow reinvestment rate. Propanc Biopharma, Inc. Common Stock (PPCB) has a Cash Flow Reinvestment Rate of 0.00x as of December 2024, reinvesting $5.00 (capex $5.00 ) from operating cash flow of $18.73K. Explore PPCB operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$5.00
Capex + Investments
Operating Cash Flow
$18.73K
USD
Capital Expenditures
$5.00
USD
Propanc Biopharma, Inc. Common Stock Cash Flow Reinvestment Rate by Year (None–None)
Propanc Biopharma, Inc. Common Stock cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Propanc Biopharma, Inc. Common Stock. For the full cash flow conversion analysis, see PPCB cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow